Background: The use of antibiotic stewardship programmes (ASPs) is increasing in Asia, but their effectiveness in reducing antibiotic consumption and their impact on clinical outcomes is not known. Objectives: To determine the impact of ASPs conducted in Asia on the consumption of antibiotics and on patients' clinical outcomes. Methods: We systematically searched the Embase and Medline (PubMed) databases for studies that compared antibiotic consumption or clinical outcomes of patients in an Asian hospital or clinic with an ASP (intervention) with those in a similar setting without an ASP (control). Meta-analyses of all-cause mortality and hospital-acquired infection (HAI) were performed using random-effects models. Results: The search identified 77 studies of which 22 and 19 reported antibiotic usage and cost, respectively. Among these, 20 (91%) studies reported reduced antibiotic usage and 19 (100%) reported cost savings in the intervention group. Duration of antibiotic therapy was reduced in six of seven studies in association with an ASP. Rates of all-cause mortality and HAI were not significantly different between the intervention and control groups. However, mortality rates were significantly improved by ASPs using drug monitoring, while HAI rates were also improved by ASPs that included infection control or hand hygiene programmes. Conclusions: In Asia, ASPs reduce antibiotic consumption in hospital and clinic settings and do not worsen clinical outcomes. The findings strongly support the broad implementation of antimicrobial stewardship interventions in hospital and clinic settings in Asia.
Background: The use of antibiotic stewardship programmes (ASPs) is increasing in Asia, but their effectiveness in reducing antibiotic consumption and their impact on clinical outcomes is not known. Objectives: To determine the impact of ASPs conducted in Asia on the consumption of antibiotics and on patients' clinical outcomes. Methods: We systematically searched the Embase and Medline (PubMed) databases for studies that compared antibiotic consumption or clinical outcomes of patients in an Asian hospital or clinic with an ASP (intervention) with those in a similar setting without an ASP (control). Meta-analyses of all-cause mortality and hospital-acquired infection (HAI) were performed using random-effects models. Results: The search identified 77 studies of which 22 and 19 reported antibiotic usage and cost, respectively. Among these, 20 (91%) studies reported reduced antibiotic usage and 19 (100%) reported cost savings in the intervention group. Duration of antibiotic therapy was reduced in six of seven studies in association with an ASP. Rates of all-cause mortality and HAI were not significantly different between the intervention and control groups. However, mortality rates were significantly improved by ASPs using drug monitoring, while HAI rates were also improved by ASPs that included infection control or hand hygiene programmes. Conclusions: In Asia, ASPs reduce antibiotic consumption in hospital and clinic settings and do not worsen clinical outcomes. The findings strongly support the broad implementation of antimicrobial stewardship interventions in hospital and clinic settings in Asia.
Authors: Gordon H Guyatt; Andrew D Oxman; Holger J Schünemann; Peter Tugwell; Andre Knottnerus Journal: J Clin Epidemiol Date: 2010-12-24 Impact factor: 6.437
Authors: Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079
Authors: Maria R Gualano; Renata Gili; Giacomo Scaioli; Fabrizio Bert; Roberta Siliquini Journal: Pharmacoepidemiol Drug Saf Date: 2014-09-24 Impact factor: 2.890
Authors: Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi Journal: Clin Infect Dis Date: 2016-05-15 Impact factor: 9.079
Authors: Roberta Crevelário de Melo; Bruna Carolina de Araújo; Maritsa Carla de Bortoli; Tereza Setsuko Toma Journal: Rev Panam Salud Publica Date: 2020-09-23
Authors: Jacob Pierce; Anucha Apisarnthanarak; Natalie Schellack; Wanda Cornistein; Amal Al Maani; Syamhanin Adnan; Michael P Stevens Journal: Int J Infect Dis Date: 2020-06-04 Impact factor: 3.623
Authors: Sanjeev Singh; Vidya P Menon; Zubair U Mohamed; V Anil Kumar; Vrinda Nampoothiri; Sangita Sudhir; Merlin Moni; T S Dipu; Ananya Dutt; Fabia Edathadathil; G Keerthivasan; Keith S Kaye; Payal K Patel Journal: Open Forum Infect Dis Date: 2018-11-08 Impact factor: 3.835
Authors: Jarir At Thobari; Cahya Dewi Satria; Yohanes Ridora; Emma Watts; Amanda Handley; Samad Samad; Novilia S Bachtiar; Julie E Bines; Yati Soenarto; Jim P Buttery Journal: PLoS One Date: 2019-08-05 Impact factor: 3.240
Authors: Sukhyun Ryu; Benjamin J Cowling; Peng Wu; Scott Olesen; Christophe Fraser; Daphne S Sun; Marc Lipsitch; Yonatan H Grad Journal: JAC Antimicrob Resist Date: 2019-12-10